Trulieve Cannabis Corp is a vertically integrated seed to sale and fully licensed medical marijuana company. It is mainly engaged in the cultivation, possession, use, sale, and distribution of medical cannabis.
1940
5.4K+
LTM Revenue $1.7B
LTM EBITDA $576M
$1.4B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Trulieve has a last 12-month revenue of $1.7B and a last 12-month EBITDA of $576M.
In the most recent fiscal year, Trulieve achieved revenue of $784M and an EBITDA of -$15.3M.
Trulieve expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See Trulieve valuation multiples based on analyst estimatesFY 2022 | FY 2023 | FY 2024 | LTM | NTM | |
---|---|---|---|---|---|
Revenue | $861M | $784M | $1.2B | $1.7B | XXX |
Gross Profit | $393M | $474M | $409M | XXX | XXX |
Gross Margin | 46% | 60% | 35% | XXX | XXX |
EBITDA | $154M | -$15.3M | $400M | $576M | XXX |
EBITDA Margin | 18% | -2% | 34% | 34% | XXX |
Net Profit | $12.5M | -$171M | -$366M | XXX | XXX |
Net Margin | 1% | -22% | -31% | XXX | XXX |
Net Debt | $173M | $303M | $195M | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of February 7, 2025, Trulieve's stock price is CAD 7 (or $5).
Trulieve has current market cap of CAD 1.3B (or $891M), and EV of CAD 2.0B (or $1.4B).
See Trulieve trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$1.4B | $891M | XXX | XXX | XXX | XXX | $-0.63 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of February 7, 2025, Trulieve has market cap of $891M and EV of $1.4B.
Trulieve's trades at 1.2x LTM EV/Revenue multiple, and 3.5x LTM EBITDA.
Analysts estimate Trulieve's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Trulieve and 10K+ public compsFY 2024 | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|
EV | $1.4B | XXX | XXX | XXX |
EV/Revenue | 1.2x | XXX | XXX | XXX |
EV/EBITDA | 3.5x | XXX | XXX | XXX |
P/E | -6.1x | XXX | XXX | XXX |
P/E/Growth | n/a | XXX | XXX | XXX |
EV/FCF | 10.7x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpTrulieve's NTM/LTM revenue growth is 5%
Trulieve's revenue per employee for the last fiscal year averaged $0.1M, while opex per employee averaged $0.1M for the same period.
Over next 12 months, Trulieve's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Trulieve's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Trulieve and other 10K+ public compsFY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|---|
Revenue Growth | 49% | XXX | XXX | XXX | XXX |
EBITDA Margin | 34% | XXX | XXX | XXX | XXX |
EBITDA Growth | -2723% | XXX | XXX | XXX | XXX |
Rule of 40 (SaaS-only) | 39% | XXX | XXX | XXX | XXX |
Revenue per Employee | $0.1M | XXX | XXX | XXX | XXX |
Opex per Employee | $0.1M | XXX | XXX | XXX | XXX |
S&M Expenses to Revenue | 21% | XXX | XXX | XXX | XXX |
G&A Expenses to Revenue | 13% | XXX | XXX | XXX | XXX |
R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
Opex to Revenue | 44% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Live Verdure | XXX | XXX | XXX | XXX | XXX | XXX |
Ascend Wellness Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
Ayr Wellness | XXX | XXX | XXX | XXX | XXX | XXX |
Cresco Labs | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Trulieve acquired XXX companies to date.
Last acquisition by Trulieve was XXXXXXXX, XXXXX XXXXX XXXXXX . Trulieve acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign UpWhen was Trulieve founded? | Trulieve was founded in 1940. |
Where is Trulieve headquartered? | Trulieve is headquartered in Canada. |
How many employees does Trulieve have? | As of today, Trulieve has 5.4K+ employees. |
Is Trulieve publicy listed? | Yes, Trulieve is a public company listed on CNQ. |
What is the stock symbol of Trulieve? | Trulieve trades under TRUL ticker. |
When did Trulieve go public? | Trulieve went public in 2018. |
Who are competitors of Trulieve? | Similar companies to Trulieve include e.g. Live Verdure, Ascend Wellness Holdings, Ayr Wellness, Cresco Labs. |
What is the current market cap of Trulieve? | Trulieve's current market cap is $891M |
What is the current revenue of Trulieve? | Trulieve's last 12-month revenue is $1.7B. |
What is the current EBITDA of Trulieve? | Trulieve's last 12-month EBITDA is $576M. |
What is the current EV/Revenue multiple of Trulieve? | Current revenue multiple of Trulieve is 1.2x. |
What is the current EV/EBITDA multiple of Trulieve? | Current EBITDA multiple of Trulieve is 3.5x. |
What is the current revenue growth of Trulieve? | Trulieve revenue growth between 2023 and 2024 was 49%. |
Is Trulieve profitable? | Yes, Trulieve is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.